Brief: Addex Therapeutics Q3 Operating Loss at CHF 2.7 million
29/11/2023 06:07
Nov 29 (Reuters) - Addex Therapeutics Q3 EPS CHF -0.03. * Q3 operating income CHF -2.652 million * Q3 net income CHF -2.617 million
ADXN — Addex Therapeutics News Story
0.000.00%
Last trade - 00:00- CH₣5.17m
- CH₣3.56m
- CH₣0.17m